Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
On May 21, 2021, Moderna announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted…
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
On Mar. 5, 2021,Takeda Pharmaceutical announced that it has submitted a New Drug Application to the Government of…
On Jan. 21, 2021, Moderna announced that the first participant has been dosed in the Phase 1/2 study…
On Dec. 11, 2020, Sanatech Seed Co, and sales partner Pioneer EcoScience, announced the commercial sales of Sicilian…
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
On Jun. 18, 2020, Ultragenyx Pharmaceutical and Kyowa Kirin announced that the U.S. Food and Drug Administration (FDA)…
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
On Mar. 31, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
On Mar. 9, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
On Mar. 11, 2016, Japanese scientists announced they had discovered a species of bacteria that was “eating” its…
On Jan. 11, 2016, National Aeronautics and Space Administration (NASA) research scientist David J. Smith reported finding that…
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…
On May 31, 2012, the tomato genome was published in Nature, culminating years of work by the Tomato…
In 2007, Richard Nakamura, Ph.D., became the first Asian American scientific director of the National Institute of Mental…
On Nov. 20, 1979, Dr. Robert Anderson from the University Hospital injected Fluosol, a blood substitute developed in…
In 1966, Kimishige (“Kimi”) Ishizaka, along with his wife Teruko (‘Terry’) Ishizaka, first described a new antibody isotype:…
In 1940, biochemist and bacteriologist Ruby Hirose was recognized by the American Chemical Society for accomplishments in chemistry….
In 1913, Japanese immunologist and bacteriologist Hideyo Noguchi discovered that Treponema pallidum (syphilitic spirochete) was the cause of…